Tag: Nplate

Amgen scores pediatric FDA approval for Nplate in immune thrombocytopenia

Amgen’s Nplate (romiplostim) has been approved by the US Food and Drug Administration (FDA) for the treatment of pediatric patients with immune thrombocytopenia (ITP). The ... Read More